FDA recalls over 350,000 bottles of antidepressants for increased levels of carcinogens

CINCINNATI (WKRC) – The Food and Drug Administration issued a recall for over 350,000 bottles of antidepressants for potentially containing increased levels of carcinogens.

According to two recall reports, bottles of 30 milligram and 60 milligram doses of Duloxetine were recalled due to the potential presence of an unsafe amount of N-nitroso-duloxetine impurity.

The FDA reported that exposure to these impurities “may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time.”

Specific information regarding affected lot numbers can be found in the recall reports. The products were manufactured by Breckenridge Pharmaceutical.

The products were distributed across the United States, the FDA reported.